Atherosclerotic Cardiovascular Disease (ASCVD)
25
10
12
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
4.0%
1 terminated out of 25 trials
85.7%
-0.9% vs benchmark
28%
7 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (25)
PCSK9 Inhibitors in Hyperlipidemia and Atherosclerosis
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
LDL Cholesterol Reduction Following Ezetimibe Initiation
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data
The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD
Managed Access Programs for TQJ230, Pelacarsen
Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention
Target-Oriented Strategy of Ultra-Low LDL-C (<1.0 vs. 1.0-1.39 mmol/L) in Extreme-High-Risk ASCVD Patients: Clinical Benefit, Safety and Cost-Effectiveness Assessment
Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)
Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients
Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)
A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World
Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease
A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation and hsCRP as a biomARKer in Patients With ASCVD and CKD in China Among Cardiologists and Nephrologists
Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management